HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Abstract
Experimental and clinical studies link Chlamydia pneumoniae infection to atherogenesis and atherothrombotic events, but the underlying mechanisms are unclear. We tested the hypothesis that C. pneumoniae-induced acceleration of atherosclerosis in apolipoprotein E (ApoE)(-/-) mice is reciprocally modulated by activation of TLR-mediated innate immune and liver X receptor alpha (LXRalpha) signaling pathways. We infected ApoE(-/-) mice and ApoE(-/-) mice that also lacked TLR2, TLR4, MyD88, or LXRalpha intranasally with C. pneumoniae followed by feeding of a high fat diet for 4 mo. Mock-infected littermates served as controls. Atherosclerosis was assessed in aortic sinuses and in en face preparation of whole aorta. The numbers of activated dendritic cells (DCs) within plaques and the serum levels of cholesterol and proinflammatory cytokines were also measured. C. pneumoniae infection markedly accelerated atherosclerosis in ApoE-deficient mice that was associated with increased numbers of activated DCs in aortic sinus plaques and higher circulating levels of MCP-1, IL-12p40, IL-6, and TNF-alpha. In contrast, C. pneumoniae infection had only a minimal effect on atherosclerosis, accumulation of activated DCs in the sinus plaques, or circulating cytokine increases in ApoE(-/-) mice that were also deficient in TLR2, TLR4, or MyD88. However, C. pneumoniae-induced acceleration of atherosclerosis in ApoE(-/-) mice was further enhanced in ApoE(-/-)LXRalpha(-/-) double knockout mice and was accompanied by higher serum levels of IL-6 and TNF-alpha. We conclude that C. pneumoniae infection accelerates atherosclerosis in hypercholesterolemic mice predominantly through a TLR/MyD88-dependent mechanism and that LXRalpha appears to reciprocally modulate and reduce the proatherogenic effects of C. pneumoniae infection.
AuthorsYoshikazu Naiki, Rosalinda Sorrentino, Michelle H Wong, Kathrin S Michelsen, Kenichi Shimada, Shuang Chen, Atilla Yilmaz, Anatoly Slepenkin, Nicolas W J Schröder, Timothy R Crother, Yonca Bulut, Terence M Doherty, Michelle Bradley, Zory Shaposhnik, Ellena M Peterson, Peter Tontonoz, Prediman K Shah, Moshe Arditi
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 181 Issue 10 Pg. 7176-85 (Nov 15 2008) ISSN: 1550-6606 [Electronic] United States
PMID18981139 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins E
  • Cytokines
  • DNA-Binding Proteins
  • Liver X Receptors
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • Nr1h3 protein, mouse
  • Orphan Nuclear Receptors
  • Receptors, Cytoplasmic and Nuclear
  • Toll-Like Receptors
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Animals
  • Aorta (immunology, pathology)
  • Apolipoproteins E (deficiency, genetics)
  • Atherosclerosis (metabolism, microbiology)
  • Chlamydia Infections (complications, metabolism)
  • Chlamydophila pneumoniae
  • Cytokines (blood, immunology)
  • DNA-Binding Proteins (genetics, metabolism)
  • Dendritic Cells (immunology, metabolism)
  • Fluorescent Antibody Technique
  • Gene Expression
  • Granulocyte-Macrophage Colony-Stimulating Factor (biosynthesis, genetics)
  • Hypercholesterolemia (complications)
  • Immunohistochemistry
  • Liver X Receptors
  • Mice
  • Mice, Knockout
  • Myeloid Differentiation Factor 88 (genetics, metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Orphan Nuclear Receptors
  • Receptors, Cytoplasmic and Nuclear (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (physiology)
  • Toll-Like Receptors (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: